PT91878A - Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas - Google Patents

Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas

Info

Publication number
PT91878A
PT91878A PT91878A PT9187889A PT91878A PT 91878 A PT91878 A PT 91878A PT 91878 A PT91878 A PT 91878A PT 9187889 A PT9187889 A PT 9187889A PT 91878 A PT91878 A PT 91878A
Authority
PT
Portugal
Prior art keywords
hypocolesterolemic
preparation
imidazole derivatives
hypolipidemic properties
hypolipidemic
Prior art date
Application number
PT91878A
Other languages
English (en)
Other versions
PT91878B (pt
Inventor
Barry Clive Ross
Nigel Stephen Watson
Chuen Chan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT91878A publication Critical patent/PT91878A/pt
Publication of PT91878B publication Critical patent/PT91878B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT91878A 1988-10-03 1989-10-02 Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas PT91878B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (2)

Publication Number Publication Date
PT91878A true PT91878A (pt) 1990-04-30
PT91878B PT91878B (pt) 1995-05-31

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91878A PT91878B (pt) 1988-10-03 1989-10-02 Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas

Country Status (19)

Country Link
US (2) US5013749A (pt)
JP (1) JPH02188571A (pt)
KR (1) KR900006297A (pt)
AU (1) AU628862B2 (pt)
BE (1) BE1003007A3 (pt)
CH (1) CH680442A5 (pt)
DE (1) DE3932887A1 (pt)
DK (1) DK483689A (pt)
ES (1) ES2019163A6 (pt)
FI (1) FI894648A (pt)
FR (1) FR2637183A1 (pt)
GB (1) GB2223224B (pt)
GR (1) GR890100634A (pt)
IT (1) IT1237470B (pt)
LU (1) LU87600A1 (pt)
NL (1) NL8902441A (pt)
NO (1) NO893909L (pt)
PT (1) PT91878B (pt)
SE (1) SE8903226L (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
AU637408B2 (en) * 1989-10-10 1993-05-27 Glaxo Group Limited Substituted N-vinyl imidazole derivatives.
JPWO2002030425A1 (ja) * 2000-10-12 2004-02-19 日産化学工業株式会社 糖尿病合併症予防・治療剤
IL158300A0 (en) * 2001-04-27 2004-05-12 Bristol Myers Squibb Co Bisarylimidazol derivatives and pharmaceutical compositions containing the same
MXPA06011657A (es) * 2004-04-16 2007-04-23 Warner Lambert Co Nuevos imidazoles.
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
WO2006028524A2 (en) * 2004-04-29 2006-03-16 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (en) 2010-10-06 2014-03-19 Univ Tokyo A MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF A DERY LYMPH

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
HUT48208A (en) * 1985-10-25 1989-05-29 Sandoz Ag Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
JPS6322056A (ja) * 1986-04-30 1988-01-29 サンド・アクチエンゲゼルシヤフト オレフイン性化合物の製造法
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
US5013749A (en) 1991-05-07
DK483689D0 (da) 1989-10-02
IT1237470B (it) 1993-06-07
NO893909D0 (no) 1989-10-02
AU4243189A (en) 1990-04-05
KR900006297A (ko) 1990-05-07
JPH02188571A (ja) 1990-07-24
GR890100634A (el) 1990-11-29
GB8922212D0 (en) 1989-11-15
PT91878B (pt) 1995-05-31
US5120848A (en) 1992-06-09
LU87600A1 (fr) 1990-05-15
FR2637183A1 (fr) 1990-04-06
SE8903226L (sv) 1990-04-04
FI894648A (fi) 1990-04-04
IT8948424A0 (it) 1989-10-02
AU628862B2 (en) 1992-09-24
GB2223224B (en) 1992-01-08
GB2223224A (en) 1990-04-04
CH680442A5 (pt) 1992-08-31
NO893909L (no) 1990-04-04
DE3932887A1 (de) 1990-04-05
FI894648A0 (fi) 1989-10-02
DK483689A (da) 1990-04-04
NL8902441A (nl) 1990-05-01
ES2019163A6 (es) 1991-06-01
SE8903226D0 (sv) 1989-10-02
BE1003007A3 (fr) 1991-10-22

Similar Documents

Publication Publication Date Title
PT90119A (pt) Processo para a preparacao de um adocante
PT90293A (pt) Processo para a preparacao de macrolidos
PT91878A (pt) Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas
PT89780A (pt) Processo para a preparacao de derivados da tetrahidroisoquinolina
PT92325A (pt) Processo para a preparacao de polieter-poliois com insaturacao reduzida
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT90854A (pt) Processo para a preparacao de 1-aril-2-naftoilaminas
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
BR8903429A (pt) Heteropolissacarideo bm07 e processo para a preparacao do mesmo e aplicacao do heteropolissacarideo bm07
PT91066A (pt) Processo para a preparacao de derivados de eter n-fenilpirazol-4-ilico
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT94008A (pt) Processo para a preparacao de novos derivados de tieno-triazolo-diazepina
PT90375A (pt) Processo para a preparacao de derivados de quinazolina com efeito anti-tumoralc
PT91048A (pt) Processo para a preparacao de compostos afins das avermectinas e milbemicinas
BR8903367A (pt) Processo para a preparacao de organoclorossilanos
PT89954B (pt) Processo para a preparacao de pirroloquinolina-e pirrolofenotiazina-carboxamidas e de compostos afins
BR8902030A (pt) Processo para a preparacao de n-fosfonometilglicina
BR8901209A (pt) Processo para a preparacao de corantes reativos e aplicacao dos mesmos
PT92507A (pt) Processo para a preparacao de alfa-ciano-beta-oxopropionamidas
BR8901342A (pt) Polidiorganosiloxano e processo de preparacao do mesmo
BR8906056A (pt) Processo para a preparacao de alcanosulfonamidas
PT90588A (pt) Processo para a preparacao de dibenzotiofenos substituidos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941123

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960531